IC 107-2024: The Changing Paradigm of Posterior Shoulder Instability: From Simple Repair to Arthroscopic Bone Block
Image For Activity Cover
Availability
On-Demand
Expires on Sep 30, 2027
Cost
Member: $20.00
Resident/Fellow Member: $20.00
Affiliate Member: $20.00
Non-Member: $30.00
Credit Offered
1.5 CME Credits
1.5 Category A CEU Credits
  • Course Information
  • ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 107: The Changing Paradigm of Posterior Shoulder Instability: From Simple Repair to Arthroscopic Bone Block

Course Description:

Much has been learned regarding posterior shoulder instability over the recent years, including its unique differences and the fact that posterior instability may be more common than anterior instability. Further knowledge regarding posterior instability's different injury pattern, symptoms, clinical presentation, bone loss patterns, and surgical treatment and outcomes have expanded exponentially. Despite this, many patients still are not appropriately diagnosed and treated. This course provides an overview of these unique issues in this cohort and how operative treatments should be approached, including surgical pearls with a case-based discussion. This panel of experts with extensive experience in treating professional athletes to weekend warriors will provide insights into the latest understanding of pathologies and treatments patients with posterior shoulder instability.

Learning Objectives:

  • Identify important history and physical exam findings of those with posterior instability and how they differ from anterior instability patients.
  • Understand posterior instability glenoid bone loss, how to measure it, and how it differs from anterior glenoid bone loss.
  • Understanding how throwers develop posterior shoulder instability in a different mechanism then others, and how treatment of throwers differs.
  • Learn tips and tricks of arthroscopic repair.
  • Learn tips and tricks of glenoid osteotomy and bone block augmentation and when this may be indicated.

Faculty:

  • Justin W. Arner, MD
  • Jonathan F. Dickens, MD
  • Brett D. Owens, MD
  • Matthew T. Provencher, MD, MBA, MC USNR (Ret.)
  • Brian R. Waterman, MD
Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

 

Disclosures

 

Name Disclosure Details
Arner, Justin (MD) No Relevant Financial Relationships
Dickens, Jonathan (MD) Royalties, Financial or Material Support from Publishers relationship with SLACK Inc
Owens, Brett (MD) Stock or Stock Options relationship with Vivorte; Paid Consultant relationship with Vericel; Paid Consultant relationship with Mitek; Royalties relationship with Conmed; Research Support relationship with Arthex; Research Support relationship with Mitek; Royalties, Financial or Material Support from Publishers relationship with Elsevier; Royalties, Financial or Material Support from Publishers relationship with Slack; Royalties, Financial or Material Support from Publishers relationship with Springer; Royalties, Financial or Material Support from Publishers relationship with AJSM; Research Support relationship with MTF
Provencher, Matthew (MD, MBA) Research Support relationship with Icarus Medical; Research Support relationship with DJO; Research Support relationship with Canon; Research Support relationship with Arthrex, Inc.; Paid Consultant relationship with Arthrex, Inc.; Speaker's Bureau/Presenter relationship with Arthrex, inc.; Royalties relationship with Anika Therapeutics, Inc.; Royalties relationship with Arthrex, Inc.; Other Financial or Material Support relationship with Medwest Associates; Research Support relationship with Medtronic; Research Support relationship with SubioMed; Other Financial or Material Support relationship with Joint restoration Foundation, Inc.; Other Financial or Material Support relationship with Arthrex, Inc.; Research Support relationship with Ossur; Research Support relationship with Smith+Nephew; Other Financial or Material Support relationship with Bioventus, LLC; Other Financial or Material Support relationship with Gemini Mountain Medical, LLC; Other Financial or Material Support relationship with DJO, LLC; Research Support relationship with Stryker; Other Financial or Material Support relationship with Innovation Technologies, Inc; Research Support relationship with Wright Medical; Other Financial or Material Support relationship with MEDACTA USA, Inc.
Waterman, Brian (MD) Other Financial or Material Support relationship with fellowship funding: Smith & Nephew, Arthrex; Paid Consultant relationship with arthrex, vericel; Speaker's Bureau/Presenter relationship with arthrex, vericel; Stock or Stock Options relationship with vivorte, sparta, kaliber AI
 

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 10/01/2024
EXPIRATION DATE: 09/30/2027

Android App Download IOS App Download Powered By